Advertisement
Screener

GILEAD SCIENCES, INC. (GILD) Material Contracts, 2019

GILEAD SCIENCES, INC. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2019-11-05: Form 10-Q; Exhibit 10.50; Description OPTION, LICENSE AND COLLABORATION AGREEMENT (GALAPAGOS).
  • 2019-11-05: Form 10-Q; Exhibit 10.31; Description SEVERANCE AGREEMENT (MCHUTCHISON).
  • 2019-11-05: Form 10-Q; Exhibit 10.30; Description SEVERANCE AGREEMENT (ALTON).
  • 2019-11-05: Form 10-Q; Exhibit 10.24; Description SEVERANCE PLAN (AMENDED AND RESTATED).
FiledFormExhibitDescription
2019-11-0510-Q10.50OPTION, LICENSE AND COLLABORATION AGREEMENT (GALAPAGOS)
2019-11-0510-Q10.31SEVERANCE AGREEMENT (MCHUTCHISON)
2019-11-0510-Q10.30SEVERANCE AGREEMENT (ALTON)
2019-11-0510-Q10.24SEVERANCE PLAN (AMENDED AND RESTATED)
2019-11-0510-Q10.202019 GLOBAL EMPLOYEE RSU AGREEEMENT (4 YEAR VEST)
2019-11-0510-Q10.192019 GLOBAL EMPLOYEE RSU AGREEEMENT (3 YEAR VEST)
2019-11-0510-Q10.52019 GLOBAL EMPLOYEE STOCK OPTION AGREEEMENT (4 YEAR VEST)
2019-10-158-K10.1Letter dated October 11, 2019 between Gilead Sciences, Inc. and Andrew Dickinson.
2019-08-0610-Q10.30RSU AGREEMENT (O'DAY)
2019-08-0610-Q10.29PSU AGREEMENT-REVENUE GOALS (O'DAY)
2019-08-0610-Q10.28PSU AGREEMENT-TSR GOALS (O'DAY)
2019-08-0610-Q10.27STOCK OPTION AGREEMENT (O'DAY)
2019-08-0610-Q10.26OFFER LETTER (MERCIER)
2019-08-0610-Q10.202005 DEFERRED COMPENSATION PLAN (AMENDED)
2019-08-0610-Q10.182019 DIRECTOR RSU AGREEMENT
2019-08-0610-Q10.172019 EMPLOYEE RSU AGREEMENT
2019-08-0610-Q10.152019 PSU AGREEMENT-REVENUE GOALS
2019-08-0610-Q10.122019 PSU AGREEMENT-TSR GOALS
2019-08-0610-Q10.92019 DIRECTOR STOCK OPTION AGREEMENT
2019-08-0610-Q10.42019 EMPLOYEE STOCK OPTION AGREEMENT
2019-04-1810-K/A10.43MASTER AGREEMENT BY AND BETWEEN REGISTRANT AND JAPAN TOBACCO INC
2019-04-1810-K/A10.42AMENDED AND RESTATED EVG LICENSE AGREEMENT
2019-02-2610-K10.43MASTER AGREEMENT BY AND BETWEEN REGISTRANT AND JAPAN TOBACCO INC
2019-02-2610-K10.42AMENDED AND RESTATED EVG LICENSE AGREEMENT

Similar stocks

Stock NameCountryMarket CapPE Ratio
AMGEN INC (AMGN)United States$219.567B22.39
Moderna, Inc. (MRNA)United States$77.819B-8.86
Revolution Medicines, Inc. (RVMD)United States$42.805B-22.69
BIOGEN INC. (BIIB)United States$33.427B19.60
EXELIXIS, INC. (EXEL)United States$14.358B16.15
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31